Industry Analysis & Industry Trends
In 2013, revenue for the Pharmaceutical Manufacturing industry is expected to total $94.4 billion, up 14.5% from 2012. This represents an annualized growth rate of 18.8% since 2008. The industry's profitability has also been increasing – from 10.3% of industry revenue in 2008 to 10.9% in 2013. There are about 1,417 industry enterprises in 2013, employing about 602,031 people with a payroll of about $5.8 billion.
Hospitals are currently the main distribution channel for medicines produced by this industry. However, upcoming healthcare reforms will enable drugstores to become the major distribution channel in the near future. In the past, many consumers could not afford to purchase medicine or see a doctor.... purchase to read more
Industry Report - Industry Key Buyers Chapter
Industry concentration measures the extent to which a small number of companies dominate an industry. In recent years, concentration levels in the global pharmaceutical industry have increased as major players merged to minimize rising R&D costs, reduce development times and increase global marketing power. The lure of lower costs and a large domestic market in China has attracted many global firms to enter the Chinese market.
Within the Pharmaceutical Manufacturing industry in China, concentration is low, with the top four players accounting – Jiangsu Yangtze River Pharmaceutical Group, Harbin Pharmaceutical Group, Xian-Janssen Pharmaceutical Ltd, Bayer Healthcare – for 12.8% of total industry revenue in 2013... purchase to read more